Day: November 13, 2020

New Phase 3 Data at AASLD Show Durable Response to Odevixibat in a Rare Pediatric Liver Disease

Written by Customer Service on November 13, 2020. Posted in Public Companies.

– PEDFIC 1 meets both U.S. and EU primary and secondary endpoints with highly statistically significant reductions in serum bile acids and pruritus –– Interim results from long-term extension study show sustained improvements in serum bile acids, pruritus –– Improvements in growth measures and liver parameters observed with long-term administration suggests disease modifying potential of odevixibat –– Treatment effect consistent across wide range of PFIC patient types 1, 2 and 3 –– Next-generation, novel bile acid modulators for adult liver diseases unveiled, including compound A3907 –BOSTON, Nov. 13, 2020 (GLOBE NEWSWIRE) — Albireo Pharma, Inc. (Nasdaq: ALBO), a clinical-stage rare liver disease company developing novel bile acid modulators, today announced new data in...

BankBazaar Plans 500 New Hires By March 2021

Written by Customer Service on November 13, 2020. Posted in Public Companies.

National, November 12, 2020: BankBazaar.com, India’s leading free credit score provider and online financial product marketplace, announced comprehensive hiring plans to support business expansion. The company, which recently announced that its revenues are back to 70% of the peak pre-Covid revenue, has plans to scale up its digital KYC offerings to facilitate contactless access to credit. Majority of the 500+ hires would be for the Technology and Customer Service domains as BankBazaar looks to accelerate innovation and enable faster integration of Digital KYC and analytics solutions – the key growth drivers for the company. Hiring will take place across all BankBazaar locations in Chennai, Bangalore, and Mumbai. BankBazaar had a great run in the first five months of H2-FY20 and was trending to hit EBITDA positivity when Covid-19 hit in...

Pieridae Announces Third Quarter Results

Written by Customer Service on November 13, 2020. Posted in Earnings Releases And Operating Results.

NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES ORDISSEMINATION IN UNITED STATESHighlights:Revenue (net of royalties) of $54.6 million in Q3 2020, an increase of $41.4 million or 315% compared to Q3 2019Net operating income1 (“NOI”) increased by $2.1 million or 76% compared to Q3 2019Adjusted Funds Flow From Operations1 (“AFFO”) increased by $0.9 million or 13% compared to Q3 2019Q3 2020 average production was 38,209 barrels of oil equivalent per day (“boe/day”), an increase of 23,552 boe/day or 161% compared to Q3 2019Completed deferred maintenance to ensure the continued, safe and reliable operation of our assetsCALGARY, Alberta, Nov. 13, 2020 (GLOBE NEWSWIRE) — Pieridae Energy Limited (“Pieridae” or the “Company”) (PEA.TO) released its Q3 2020 results today, highlighted by the fact the Company recorded year-over-year...

Knight Therapeutics Reports Third Quarter 2020 Results

Written by Customer Service on November 13, 2020. Posted in Earnings Releases And Operating Results.

MONTREAL, Nov. 13, 2020 (GLOBE NEWSWIRE) — Knight Therapeutics Inc. (TSX: GUD) (“Knight” or “the Company”), a leading pan-American (ex-US) specialty pharmaceutical company, today reported financial results for its third quarter ended September 30, 2020. All currency amounts are in thousands except for share and per share amounts. All currencies are Canadian unless otherwise specified.Q3 2020 Highlights

Thérapeutique Knight publie ses résultats du troisième trimestre 2020

Written by Customer Service on November 13, 2020. Posted in Earnings Releases And Operating Results.

MONTRÉAL, 13 nov. 2020 (GLOBE NEWSWIRE) — Thérapeutique Knight inc. (TSX : GUD) (« Knight » ou « la Société »), société pharmaceutique spécialisée panaméricaine (ex-ÉU) et chef de file, a publié aujourd’hui ses résultats financiers du troisième trimestre clos le 30 septembre 2020. Tous les montants sont exprimés en milliers à l’exception du nombre d’actions et des montants par action. Toutes les monnaies sont canadiennes, sauf indication contraire.Faits saillants du T3 2020

Meridian Bioscience Reports Strong Fourth Quarter and Record Full-Year Fiscal 2020 Operating Results and Provides Fiscal 2021 Guidance

Written by Customer Service on November 13, 2020. Posted in Earnings Releases And Operating Results.

CINCINNATI, Nov. 13, 2020 (GLOBE NEWSWIRE) — Meridian Bioscience, Inc. (NASDAQ: VIVO) today announced financial results for the fourth quarter and fiscal year ended September 30, 2020.Fourth Quarter 2020 Highlights (Comparison to Fourth Quarter Fiscal 2019):Consolidated Net Revenue of $64.2 million, up 26% year-over-yearLife Science segment delivers revenue of $34.4 million, up 97% year-over-yearDiagnostics segment revenues decreased 11% year-over-year to $29.8 million, a stronger than expected rebound from Q3 FY20, up 38% quarter-over-quarterLaunched various SARS-CoV-2 antibody pairs, designed for highly sensitive rapid antigen tests (for saliva and nasopharyngeal samples)Full Fiscal Year 2020 Highlights (Comparison to Full Year Fiscal 2019):Consolidated Net Revenue of $253.7 million, up 26% year-over-yearLife Science segment delivers...

Man Group PLC : Form 8.3 – Elementis plc

Written by Customer Service on November 13, 2020. Posted in Mergers And Acquisitions.

FORM 8.3PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BYA PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”)1. KEY INFORMATION2. POSITIONS OF THE PERSON MAKING THE DISCLOSUREIf there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)All interests and all short positions should be disclosed.Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should...

The new shares of NoHo Partners Plc have been registered into the Trade Register and the book-entry system of Euroclear Finland Oy

Written by Customer Service on November 13, 2020. Posted in Public Companies.

NoHo Partners PlcSTOCK EXCHANGE RELEASE 13 November 2020 at 14:15The Board of Directors of NoHo Partners Plc has on 9 November 2020 resolved on a directed share issue without payment to the key employees of the company in order to pay the reward for the first earning period of the long-term share-based incentive plan from 1 December 2018 to 31 December 2019. The stock exchange release concerning the directed share issue without payment was published on 9 November 2020.A total of 68 597 new shares of NoHo Partners Plc subscribed in the directed share issue without payment have been registered into the Trade Register on 13 November 2020 and admitted into the book-entry system of Euroclear Finland Oy. Following the registration of the new shares, the total number of shares in NoHo Partners Plc is 19 222 270. The new shares are intended to...

NoHo Partners Oyj:n uudet osakkeet on rekisteröity kaupparekisteriin ja Euroclear Finland Oy:n ylläpitämään arvo-osuusjärjestelmään

Written by Customer Service on November 13, 2020. Posted in Public Companies.

NoHo Partners OyjPÖRSSITIEDOTE 13.11.2020 klo 14.15NoHo Partners Oyj:n hallitus on 9.11.2020 päättänyt suunnatusta maksuttomasta osakeannista yhtiön avainhenkilöille osakepalkkiojärjestelmän ensimmäiseltä ansaintajaksolta 1.12.2018-31.12.2019 ansaitun palkkion maksamiseksi. Suunnatusta maksuttomasta osakeannista on tiedotettu 9.11.2020 julkaistulla pörssitiedotteella.NoHo Partners Oyj:n suunnatussa maksuttomassa osakeannissa 68 597 yhtiön uutta osaketta on rekisteröity 13.11.2020 kaupparekisteriin ja liitetty Euroclear Finland Oy:n ylläpitämään arvo-osuusjärjestelmään. Uusien osakkeiden rekisteröinnin myötä NoHo Partners Oyj:n osakkeiden kokonaismäärä on 19 222 270 osaketta. Uudet osakkeet on tarkoitus ottaa julkisen kaupankäynnin kohteeksi Nasdaq Helsinki Oy:n pörssilistalla arviolta 16.11.2020.Lisätietoja:Aku Vikström, toimitusjohtaja,...

RioCan Real Estate Investment Trust Announces November 2020 Distribution

Written by Customer Service on November 13, 2020. Posted in Public Companies.

TORONTO, Nov. 13, 2020 (GLOBE NEWSWIRE) — RioCan Real Estate Investment Trust (“RioCan”) (TSX: REI.UN) today announced a distribution of 12 cents per unit for the month of November. The distribution will be payable on December 7, 2020 to unitholders of record as at November 30, 2020.About RioCanRioCan is one of Canada’s largest real estate investment trusts. RioCan owns, manages and develops retail-focused, increasingly mixed-use properties located in prime, high-density transit-oriented areas where Canadians want to shop, live and work. As at September 30, 2020, our portfolio is comprised of 221 properties with an aggregate net leasable area of approximately 38.4 million square feet (at RioCan’s interest) including office, residential rental and 16 development properties.Information contact:Kim LeeVice President, Investor...

Day: November 13, 2020

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals